Testimonials From Principles of Pharma Market Access in Europe
Great course! Really valuable and practical information about the world of payers, delivered by professionals. I’d highly recommend it to everyone involved in market access.
Acccord HealthcareOlga Diachenko, Market Access Manager Europe - Czech Republic - October 2017
Thank you for 2 perfect days with a lot of useful information.
Yuria PharmaIryna Rozhnovska, Business Development Manager - Ukraine - October 2017
Professional experts and organizers. The course was very beneficial and very informative.
JulpharMohamed Adel Hegazi, Market Access Manager - United Arab Emirates - October 2017
Very useful training, I've improved my understanding of national systems in Europe. Also, I've strengthened my knowledge of general aspects of market access. I will recommend this training to my colleagues.
TakedaBozena Drewicz, Sr. Director, Market Access and Preparedness, The Americas - Switzerland - May 2017
Very informative course, would recommend to anyone who wants to learn more about market access.
GlobalDataElizabeth Hamson, Healthcare Analyst - United Kingdom - May 2017
Another great course giving valuable insights into the A-Z of Market Access – with top experts delivering complex information in easily understandable chunks.
AstellasLorraine Tweddle, Associate Brand Director - United Kingdom - May 2017
Learning and discussing market access with international experts like Mark and Nick really helps you in building future strategy that best responds to the demands of changing healthcare systems.
Bristol-Myers SquibbCatalina Moinescu, Customer Marketing Manager Virology - Romania - December 2016
Great course! Nice to be a part of it and learn from 2 specialists with loads of insights and advice. The group work on developing a Market Access Plan was SUPER!
MundipharmaChristiane Bullmann, Medical Affairs Manager - United Kingdom - December 2016
High quality course in terms of both content and practical arrangements. I also highly valued the interaction between participants. Thank you!
UCBJérémy Peaudecerf, Operational Excellence Project Manager - Belgium - December 2016
This was a great educational experience. I gained a lot of new insights and useful information – Highly recommendable!
AstraZenecaNikolina Škaron, Market Access, Pricing & Government Affairs Manager - Croatia - December 2016
Excellent course describing Market Access fundamentals for the EU5 – Highly recommended!
Receptos (Celgene)Daniel Cole, Director Market Access - United States - September 2016
Thank you – very useful! I feel more confident now :)
Novo NordiskRebecca Currie, Senior Global Public Affairs Manager - Denmark - September 2016
An excellent course giving a thorough EU5 view on Market Access systems and valuable tools and frameworks to easily apply to my current and/or future projects!
NorgineVasudha Bajaj, Senior Global Business Intelligence Analyst - United Kingdom - September 2016
I really enjoyed this C.E.L.forpharma course and gained a lot: I now have a good overview of Market Access and am able to compare healthcare systems and apply that to non-EU5 countries – exactly what I needed!
Integro PharmacyDavid Hammond, Commercial Director - United Kingdom - June 2016
Mark Silvey and Nick Proctor are very experienced. Their course provides a comprehensive overview of Europe’s major markets and offers many insights as well as good discussions – highly recommendable!
AstellasDr. Anne-Katrin Neumann, Senior Manager Market Access - Switzerland - June 2016
C.E.L.forpharma’s Market Access course answered all of my questions and filled a lot of the gaps I had! Everything was extremely interesting and useful - I really learnt a lot!
AmgenOlivia McDermid, Project Manager - Value Based Healthcare - Switzerland - June 2016
I greatly appreciate this thorough introduction to market access, given by enthusiastic expert speakers in the field.
Xellia PharmaceuticalsBeate Rygg Johnsen, Portfolio Manager - Norway - December 2015
A great professional "duo" driving us through the world of payers in the EU.
NovartisChristophe Gerbeau, Head Market Access Early Products - France - December 2015
As someone who is keenly interested in a more holistic approach to drug development and commercialisation, I found the course to be very useful in providing both a broad context as well as sufficient detail to understand successful strategies for developing and implementing an effective market access plan.
BiogenDr. Vijaya Raman-Chandra, Sr. Director & Head Global Medical Writing - United States - December 2015
Useful course, good experts and amazing organisation!
LillyFernando Granell, Payer Strategy Manager - Spain - December 2015
It's been a pleasure being able to participate in this training. Nick & Mark, you make difficult things easy: It's been great learning with & from you!
LillyMónica Chaler Milián, Corporate Affairs - Spain - December 2015
I'm very impressed by the extensive knowledge and expertise of the trainers. Receiving relevant information in an overview form was important for me. I recommend this course, as all I needed was given.
CSL BehringAlexander Wilke, Director Health Care Policy & External Affairs - Germany - September 2015
Very good and comprehensive overview of what Market Access means and embraces. Rich and interactive course, greatly balancing concepts, real pharma cases and exercises. Thank you!
SanofiRoselyne Beaux, Project Director Operations, Global Market Access - France - September 2015
Both Lloyd and Nick have extensive knowledge of the Market Access principles and the diversified environment in the EU. They delivered an excellent course full of real life examples.
PfizerYannis Apostolakis, Senior Brand Manager - France - September 2015
I personally attended the Market Access course and many other Chiesi employees participated in other courses ... with the same output … great attendance and great value!
ChiesiUgo Bettini, Corporate Head Human Resources & Organization - Italy - August 2015
Really valuable insights into differences but also similarities between key markets, their processes and stakeholder needs. Thanks!
TevaJelle Kleijn, Market Access Lead OncoCare & Womens Health Europe - The Netherlands - May 2015
This course helped me to better understand Market Access principles, which in turn enables me to give more precise strategic consulting to our customers.
Veeva SystemsRoland Seibt, Senior Consultant KOL Solutions - Germany - May 2015
This was one of the best courses I've taken in the field of executive education. Both instructors are very knowledgeable, patient and have a wicked sense of humor. I highly recommend it!
Novo NordiskAnirvan Dutt-Chaudhuri, Global Product Manager - Switzerland - December 2014
Excellent content and fantastic delivery. Good balance between 'academic' information and exercises. Thank you!
Bristol-Myers SquibbAnne Vandevoorde, Director Customer Insight & Analytics Europe - France - December 2014
Very useful and practical training! Every marketer at every level should take it!
ShireEva Panarese, Associate International Product Director - Belgium - December 2014
Thank you very much, this Market Access course is very helpful!
ShireNicole, Global Marketing - Switzerland - October 2014
This course not only has a diverse audience, you also benefit from good interactions with other participants.
GenzymeRegine Buffels, Director Medical Affairs MS EMEA - Switzerland - October 2014
Excellent overview! Both speakers have a high level of expertise and share up-to-date information during the 2 days. Really great!
ServierElena Liliana Louette, Training Manager - France - May 2014
A good overview and introduction to the MA systems in Big-5! Lloyd and Mark were very knowledgeable and gave great examples.
SOBIBodil Jonason, Executive Director Global Marketing - Sweden - September 2013
The training was very well built-up and gives a lot of insight into the world of the payers and how they are thinking. It was very useful!
ThromboGenicsCaroline van Mol, Project Coordinator Market Access - Belgium - September 2013
Possibly the ultimate shortcut to get a basic understanding of Market Access in the EU5 without being just an academic exercise.
JNB McCann HealthcareChristopher Funk, Director Strategic Planning - Germany - September 2013
Excellent course to get an overview on Market Access in Europe. Good concept to have 2 speakers (real experts) and to switch after a set of presentations.
RocheManfred Mülchi, Health Care Affairs Manager - Switzerland - June 2013
A very well planned course with the right mix of lecturing and interaction. The expertise of Lloyd and Mark transforms very well.
Molecule ConsultancyMette Sorensen, Managing Director - Denmark - June 2013
A top line overview enriched with interactive, real life discussions with true experts leading to valuable take home thoughts. Looking forward to my next CELforpharma course.
TillottsSandra Haas, Product Manager - Switzerland - June 2013
Very good introduction course of Pharma Market Access in Europe, very complete information. Huge, useful docs to be reviewed at home, which is really great.